Prostate Cancer - Results from #27580

Evolution from active surveillance to focal therapy in the management of prostate cancer - Abstract July 5, 2011

Recent advances in immunotherapy for the treatment of prostate cancer - Abstract July 5, 2011

Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population - Abstract July 5, 2011

Clinical outcomes of prostate cancer patients detected by prostate-specific antigen-based population screening in Kanazawa City, Japan - Abstract July 5, 2011

BMP4 promotes prostate tumor growth in bone through osteogenesis - Abstract July 4, 2011

Radiation therapy for prostate cancer after prostatectomy: Adjuvant or salvage? - Abstract July 4, 2011

Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients - Abstract July 4, 2011

Normal prostate-derived stromal cells stimulate prostate cancer development - Abstract July 4, 2011

Surgical margin status among men with organ-confined (pT2) prostate cancer: A population-based study - Abstract July 4, 2011

Randomized study evaluating testosterone recovery using short-versus long-acting luteinizing hormone releasing hormone agonists - Abstract July 4, 2011

Protein-network modeling of prostate cancer gene signatures reveals essential pathways in disease recurrence - Abstract July 4, 2011

Editor's Commentary - The effect of demographic and clinical factors on the relationship between BMI and PSA levels July 4, 2011

Vitamin D metabolism and action in the prostate: Implications for health and disease - Abstract July 1, 2011

Variable prostate-specific antigen management patterns by nonurologist providers at a tertiary care medical center - Abstract July 1, 2011

Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy - Abstract July 1, 2011

Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy - Abstract July 1, 2011

Palliative radiotherapy for bone metastases in the last 3 months of life: Worthwhile or futile? - Abstract July 1, 2011

Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery - Abstract July 1, 2011

Concordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patients - Abstract July 1, 2011

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers - Abstract July 1, 2011

Page 1380 of 1437